Evaluation of immunomodulator effect with lymphopenia and other side effects in relapsing-remitting multiple sclerosis patients using fingolimod: Clinical data preliminary results

Guler, S.2024-06-122024-06-1220170022-510X1878-5883https://doi.org/10.1016/j.jns.2017.08.3446https://hdl.handle.net/20.500.14551/2563623rd World Congress of Neurology (WCN) -- SEP 16-21, 2017 -- Kyoto, JAPAN[Abstract Not Available]en10.1016/j.jns.2017.08.3446info:eu-repo/semantics/closedAccess[No Keywords]Evaluation of immunomodulator effect with lymphopenia and other side effects in relapsing-remitting multiple sclerosis patients using fingolimod: Clinical data preliminary resultsConference Object381437437Q3WOS:000427450301432